Faeth Therapeutics to host virtual event on PIK-201 Phase 2 trial results

FTH•2026-11-06

Faeth Therapeutics will host a virtual event on Nov. 9, 2026, at 8 a.m. ET, to discuss topline Phase 2 PIK-201 results in advanced endometrial cancer.

1. Event details

The event will feature principal investigator David Starks and discuss results evaluating PIKTOR in advanced endometrial cancer.

Faeth Therapeutics to host virtual event on PIK-201 Phase 2 trial results

1. Event details

Related News

Victory Capital faces shareholder lawsuits alleging misleading disclosures on First Eagle deal

Block director Anthony Mathew Eisen sells $3.06 million in common shares

Profusa lowers conversion price floor to $0.20 on NorthView Sponsor I note

Xeris Biopharma President and COO Kevin McCulloch reports sale of shares worth $312,215

American Healthcare REIT enters $1.75 billion at-the-market equity offering agreement